For UTI went to give nitrofurantoin, ciprofloxacin, cefixime., trimethoprim plus sulphamethoxazole
Reading File
Finding Sources
Finding Sources
Searching PubMed
"urinary tract infection" AND "antibiotic treatment" AND nitrofurantoin
Reading File
Reading File
Finding Sources
Excellent data. Now I have a thorough picture. Here is a detailed comparison of all four antibiotics for UTI:
UTI Antibiotics: Nitrofurantoin vs Ciprofloxacin vs Cefixime vs TMP-SMX
Quick Summary of Guideline Hierarchy
For uncomplicated lower UTI (acute cystitis) in non-pregnant adults, current IDSA and emergency medicine guidelines rank these agents as:
| Priority | Drug | Role |
|---|---|---|
| First-line | Nitrofurantoin | Preferred for uncomplicated cystitis |
| First-line | TMP-SMX | Preferred when resistance <20% locally |
| NOT first-line | Ciprofloxacin | Reserve for complicated UTI / treatment failure |
| Limited role | Cefixime | Oral third-gen ceph; not routinely recommended |
1. Nitrofurantoin
Spectrum: Active against most gram-positive and gram-negative urinary pathogens (especially E. coli). Inactive against Proteus, Pseudomonas, and Klebsiella (variable).
Mechanism: Converted intracellularly to reactive intermediates by bacterial reductases - disrupts ribosomal proteins, RNA/DNA/protein synthesis simultaneously. Resistance develops slowly and there is no cross-resistance with other antibiotics.
Dose: 100 mg orally four times daily (standard); or 100 mg twice daily (macrocrystalline/Macrobid formulation) for 5 days.
Key advantages:
- Maintains low serum but very high urine concentrations - ideal for bladder infections
- Resistance among E. coli remains low even as TMP-SMX and fluoroquinolone resistance has risen
- Inexpensive
Contraindications / cautions:
- Do NOT use for upper UTI (pyelonephritis) - inadequate tissue/parenchymal levels
- Renal impairment: Contraindicated if CrCl < 30-60 mL/min (conflicting thresholds; traditional cutoff is CrCl <60 mL/min, but short-term use may be acceptable >30 mL/min)
- Hemolytic anemia in G6PD deficiency
- Pulmonary toxicity/fibrosis with prolonged use
- Nausea, vomiting (most common side effects)
- Antagonizes nalidixic acid and some fluoroquinolones (including ciprofloxacin)
2. Trimethoprim-Sulfamethoxazole (TMP-SMX / Co-trimoxazole)
Spectrum: Broad gram-negative coverage including E. coli, Klebsiella; some gram-positives.
Mechanism: Dual sequential blockade of folate synthesis - sulphamethoxazole inhibits dihydropteroate synthase; trimethoprim inhibits dihydrofolate reductase. Bactericidal synergy.
Dose: 160/800 mg (DS tablet) twice daily for 3 days for uncomplicated cystitis.
Key advantages:
- Short 3-day course
- Excellent tissue penetration (good for prostate, renal parenchyma)
- Well-studied efficacy and low cost
Key limitations:
- Avoid when local resistance >20% (IDSA recommendation) - check local antibiogram
- Rising resistance in E. coli in many regions
- Contraindicated in severe renal/hepatic impairment, pregnancy at term (kernicterus risk), G6PD deficiency
- Hypersensitivity reactions (especially in sulfa-allergic patients)
- Not recommended in significant CKD (accumulation risk)
3. Ciprofloxacin (Fluoroquinolone)
Spectrum: Excellent gram-negative coverage; moderate gram-positive (note: poor against Streptococcus); achieves therapeutic levels in renal parenchyma and prostate.
Mechanism: Inhibits DNA gyrase (topoisomerase II) and topoisomerase IV - prevents DNA replication.
Dose: 250-500 mg twice daily for 3 days (uncomplicated) or 7-14 days (complicated/pyelonephritis).
IMPORTANT - NOT first-line for uncomplicated cystitis:
- Rosen's Emergency Medicine explicitly lists ciprofloxacin as not an appropriate first-line empirical choice for uncomplicated UTI
- Should be reserved for:
- Treatment failures on first-line agents
- Complicated UTI (upper tract, structural abnormalities, catheter-associated)
- Pyelonephritis
- Prostatitis (excellent prostatic penetration)
- Patients with contraindications to first-line drugs
Why avoid for simple cystitis?
- Broad-spectrum use promotes resistance (fluoroquinolone resistance in E. coli is rising globally)
- Adverse effect profile: tendinopathy, tendon rupture, peripheral neuropathy, QT prolongation, CNS effects
- FDA black box warning for tendinitis/tendon rupture, peripheral neuropathy, CNS effects
Dose adjustment: Required for reduced GFR.
4. Cefixime (Third-Generation Oral Cephalosporin)
Spectrum: Gram-negative coverage (E. coli, Klebsiella, Proteus); poor gram-positive coverage.
Mechanism: Inhibits bacterial cell wall synthesis (beta-lactam, binds PBPs).
Dose: 200 mg twice daily or 400 mg once daily for UTI.
Key limitations:
- No longer routinely recommended for UTI due to increasing resistance (Katzung's explicitly notes this)
- Not a standard guideline-recommended choice for uncomplicated cystitis
- Main UTI use: historically in pregnancy (where nitrofurantoin and TMP-SMX have more restrictions), or as step-down therapy
- Risk: selection pressure for ESBL-producing organisms with broad-spectrum cephalosporin use
Comparison Table
| Feature | Nitrofurantoin | TMP-SMX | Ciprofloxacin | Cefixime |
|---|---|---|---|---|
| Guideline recommendation | First-line | First-line | NOT first-line | Not standard |
| Uncomplicated cystitis | Yes (5 days) | Yes (3 days) | Avoid | Limited role |
| Pyelonephritis | No | Yes | Yes (preferred) | No |
| Prostatitis | No | Yes | Yes (preferred) | No |
| Spectrum | Gram+ & Gram- (limited) | Broad | Very broad | Gram-negative |
| Resistance concern | Low (E. coli) | Moderate-high | Rising | Rising (ESBL risk) |
| Renal failure | Contraindicated | Avoid | Dose adjust | Dose adjust |
| Pregnancy | Avoid at term | Avoid at term/1st trimester | Avoid | Safer option |
| G6PD deficiency | Contraindicated | Caution | Safe | Safe |
Clinical Decision Points
- Uncomplicated cystitis in healthy woman: Nitrofurantoin 100 mg BD x 5 days OR TMP-SMX DS x 3 days (if local resistance <20%)
- Pyelonephritis: Ciprofloxacin 500 mg BD x 7 days (or IV if severe); TMP-SMX x 14 days
- Complicated UTI / treatment failure: Ciprofloxacin
- Pregnancy: Nitrofurantoin (avoid at 36+ weeks); cefixime is an alternative but check local guidelines
- CKD (CrCl <30): Avoid nitrofurantoin and TMP-SMX; use ciprofloxacin with dose adjustment
- Prostatitis: Ciprofloxacin or TMP-SMX (fluoroquinolones preferred - good prostatic penetration)
Sources: Katzung's Basic and Clinical Pharmacology, 16th Ed.; Rosen's Emergency Medicine; Goldman-Cecil Medicine; Comprehensive Clinical Nephrology, 7th Ed.
This is a shared conversation. Sign in to Orris to start your own chat.